Viagra

Viagra. It is a prescription medication primarily used to treat erectile dysfunction and, under the brand name Revatio, pulmonary arterial hypertension. Developed by researchers at Pfizer, its active ingredient sildenafil was originally investigated as a treatment for angina pectoris. The drug's mechanism involves inhibiting the enzyme phosphodiesterase type 5, enhancing blood flow to specific areas of the body.

Medical uses

The primary FDA-approved indication is for the management of erectile dysfunction, facilitating improved blood flow to the corpora cavernosa of the penis. As Revatio, it is indicated for pulmonary arterial hypertension to relax vascular smooth muscle and reduce pressure in the pulmonary circulation. It is sometimes used off-label for altitude-related conditions, such as those encountered on expeditions to Mount Everest, under the guidance of specialists from institutions like the Cleveland Clinic. Its use is contraindicated with nitrates, commonly prescribed for coronary artery disease, due to the risk of severe hypotension.

Adverse effects

Common adverse effects include headache, flushing, dyspepsia, and visual disturbances such as a blue-tinge (cyanopsia), which are typically mild and transient. More serious risks include priapism, a prolonged and painful erection requiring urgent medical intervention, and sudden hearing loss reported in cases to the FDA. The combination with nitroglycerin or other organic nitrates can precipitate a dangerous drop in blood pressure. Rare instances of non-arteritic anterior ischemic optic neuropathy have been documented in post-marketing surveillance by regulatory bodies like the European Medicines Agency.

Pharmacology

Sildenafil is a potent and selective inhibitor of phosphodiesterase type 5, an enzyme that degrades cyclic guanosine monophosphate in smooth muscle tissue. By inhibiting PDE5, it potentiates the vasodilatory effects of nitric oxide, leading to relaxation of smooth muscle in the corpus cavernosum and pulmonary vasculature. It is metabolized predominantly by the cytochrome P450 system, specifically the CYP3A4 isoenzyme, and has an active metabolite. Pharmacokinetic studies show its effects are influenced by concomitant administration of drugs like ritonavir or erythromycin, which inhibit its metabolism.

History

The compound was synthesized in 1989 by pharmaceutical scientists at Pfizer's research facility in Sandwich, Kent, led by researchers like Peter Dunn and Albert Wood. Initially coded UK-92,480, it was developed as a potential therapy for hypertension and angina pectoris during clinical trials. The serendipitous discovery of its pronounced effect on penile erections during Phase I trials redirected its development. It received approval from the Food and Drug Administration for erectile dysfunction in 1998, following landmark studies published in journals like The New England Journal of Medicine. Its subsequent approval for pulmonary hypertension in 2005 under a different brand name marked a significant expansion of its therapeutic application.

Society and culture

Its introduction had a profound social impact, significantly destigmatizing discussions about erectile dysfunction in media and popular culture. It has been referenced extensively in television shows like The Sopranos and comedy routines by figures like Bob Dole. The drug's commercial success, generating billions in revenue for Pfizer, sparked intense competition from later PDE5 inhibitors like tadalafil from Eli Lilly and Company. It has also been a focal point in debates over pharmaceutical marketing, insurance coverage, and the rise of online pharmacies. The compound's patent expiration in key markets like the United States and the European Union led to the widespread availability of generic sildenafil.

Category:Drugs